Latest Form 4 insider transactions

William R Shepard, a Director of Cme Group Inc., purchased 293 shares of common stock on September 25, 2026 for $268.76 per share.

Tco Group Holdings, L.P. reported changes in beneficial ownership of InnovAge Holding Corp. common stock on September 24, 2026.

Ignite Aggregator Lp and 5 others reported changes in beneficial ownership of InnovAge Holding Corp. common stock on September 24, 2026.

Jeffrey M Farber, Executive Vice President of Hanover Insurance Group, Inc., received 42 shares of common stock on September 25, 2026.

Jennifer Tejada, Executive Chair and a Director of PagerDuty, Inc., sold 8,000 shares of common stock on September 24, 2026 for $15.00 per share.

William D Green, a Director of Dell Technologies Inc., received 680 shares of common stock on September 24, 2026.

Nicholas Tzitzon, a Director of Acuity Brands Inc, received 296 shares of common stock on September 24, 2026.

Sanchez Oscar Iglesias, a Director of Codere Online Luxembourg, S.A., sold 460 shares of common stock on September 25, 2026 for $10.10 per share.

Peter Salovey, a Director of Legend Biotech Corp, received 28,330 shares of common stock on September 24, 2026.

Tomas J. Heyman, a Director of Legend Biotech Corp, received 20,986 shares of common stock on September 24, 2026.

Li Mao, a Director of Legend Biotech Corp, received 20,986 shares of common stock on September 24, 2026.

Patrick John Casey, a Director of Legend Biotech Corp, received 20,986 shares of common stock on September 24, 2026.

Darren Xiaohui Ji, a Director of Legend Biotech Corp, received 28,330 shares of common stock on September 24, 2026.

Corazon (Corsee) D. Sanders, a Director of Legend Biotech Corp, received 20,986 shares of common stock on September 24, 2026.

David W Dorman, a Director of Dell Technologies Inc., received 633 shares of common stock on September 24, 2026.

Jean Jacques Bienaime, a Director of Ascendis Pharma A/S, reported multiple transactions in common stock on April 14, 2026.

Erica N. Truban, a Director of F&M Bank Corp, received 102 shares of common stock on September 24, 2026.

John R Palumbo, a Director of DarioHealth Corp., received 62,000 shares of common stock on September 24, 2026.

Adam K Stern, a Director of DarioHealth Corp., reported multiple transactions in common stock on September 18, 2025.

Dennis M Mcgrath, a Director of DarioHealth Corp., received 61,000 shares of common stock on September 24, 2026.

Yoav Shaked, a Director of DarioHealth Corp., reported multiple transactions in common stock on August 12, 2024.

Chen Franco-Yehuda, Chief Financial Officer of DarioHealth Corp., received 95,000 shares of common stock on September 24, 2026.

Fabiola R Arredondo, a Director of CAMPBELL'S Co, received 2,204 shares of common stock on September 25, 2026.

Kenneth C. Greenberg, a Director of Emmis Acquisition Corp., reported a transaction in 11,667 shares of common stock on September 25, 2026.

Dennis Matheis, a Director of DarioHealth Corp., received 44,000 shares of common stock on September 24, 2026.

Jason K Garland, CFO of Repligen Corp, reported a transaction in 421 shares of common stock on September 25, 2026.

Bennett Dorrance Jr, a Director of CAMPBELL'S Co, received 2,204 shares of common stock on September 25, 2026.

Hila Karah, a Director of DarioHealth Corp., received 28,000 shares of common stock on September 24, 2026.

Sean Lie, Chief Technology Officer of Cerebras Systems Inc., sold 120,000 shares of common stock on September 25, 2026.

Maria Teresa Hilado, a Director of CAMPBELL'S Co, received 2,333 shares of common stock on September 25, 2026.